Patents/Assignees

Sandoz AG

11 patents in portfolio

US12590095utility2026
Crystalline Forms of an Orally Available, Selective Kit and PDGFR Kinase Inhibitor
0 cites
US12453826utility2025
Inhaler Device
0 cites
USD1088218design2025
Drug Delivery Device
0 cites
USD1087326design2025
Drug Delivery Device
0 cites
USD1083620design2025
Packaging
0 cites
USD1067421design2025
Inhaler
0 cites
USD1057937design2025
Drug Delivery Device
0 cites
USD1042795design2024
Drug Delivery Device
0 cites
US12043590utility2024
Co-crystals Comprising Levothyroxine and a Dicarboxylic Acid
0 cites
USD1029237design2024
Drug Delivery Device
0 cites
US11970450utility2024
Multi-component Crystals of an Orally Available HIF Prolyl Hydroxylase Inhibitor
0 cites